Dynamic Foundations of Disease XI Immune Checkpoint Inhibitor–Associated Inflammatory Arthritis as a Model of System Transition in Immune-Mediated Disease

Read full text Summarise with VIRAT
Authors: Anita Domargård
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

This paper presents immune checkpoint inhibitor–associated inflammatory arthritis (ICI-IA) as a clinical model of system transition in immune-mediated disease. Unlike most autoimmune conditions, where disease onset is inferred retrospectively, checkpoint inhibition provides a defined perturbation that enables temporal observation of how the immune system shifts from regulated tolerance to persistent inflammation. In this context, ICI-IA functions as a proof-of-transition in humans. It represents one of the first clearly observable clinical models in which disease emergence can be linked to a known starting point, allowing direct study of how biological systems cross stability thresholds and reorganize into sustained inflammatory states. The analysis reframes ICI-IA not only as an adverse event, but as a dynamical shift in system behavior. By linking immunological mechanisms to system-level concepts such as instability, feedback amplification, and attractor states, the paper highlights how autoimmune disease may arise through rapid transitions rather than gradual progression. This article forms part of a group of URM / Dynamic Medicine notes interpreting autoimmune, fibro-inflammatory, and immune-perturbation–associated diseases as system-level transitions, trajectories, and coupled multisystem processes, including rheumatoid arthritis flare, systemic lupus erythematosus flare, Sjögren’s disease, CTD-ILD, idiopathic inflammatory myositis / anti-synthetase syndrome, and immune checkpoint inhibitor–associated inflammatory arthritis. This work is part of the Dynamic Foundations of Disease series and contributes a clinically grounded example of how defined perturbations can reveal underlying transition dynamics in complex biological systems.

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Rheumatoid Arthritis Research and Therapies T-cell and B-cell Immunology

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
21 March 2026
Language
EN
Document type
Preprint